|Swarthmore College, BA|
|Economics and Public Policy|
|Harvard Business School, MBA|
Corey opened Highland’s Menlo Park office to source, evaluate and pursue West Coast-based investment opportunities across all of Highland’s targeted sectors.
Corey serves on the boards of AccentCare, Archemix, BAROnova, Fidelis, Hyperion Therapeutics, MokaFive, OpGen and Yoga Works and has been involved with Codon Devices, Conor Medsystems(IPO; acquired by Johnson & Johnson), Helicos BioSciences(Nasdaq: HLCS), NextCard (IPO), NuGenesis Technologies (acquired by Waters Corporation), Pervasis Therapeutics, Pharmaca, Telcobuy.com (merged with World Wide Technology), Turbine, US Labs (acquired by LabCorp) and XORP.
Background Prior to joining Highland in June of 1997 as a Principal, Corey worked in corporate development with ONI Systems (IPO; acquired CIENA), a San Jose-based optical networking equipment vendor. Previously, Corey worked in the investment banking group Robertson Stephens & Company and had been a Senior Associate at Highland. He began his career with The Whitman Group, a Philadelphia-based health care firm.